What is GSK plc (GLAXF)?

GSK plc (GLAXF) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

What is the current price of GLAXF?

The current price of GLAXF is $24.85. Prices are updated in real time on Stocks360.

What is GLAXF's price-to-earnings (PE) ratio?

GLAXF's trailing twelve-month PE ratio is 16.80, based on current price and earnings per share data available on Stocks360.

What is GLAXF's market capitalization?

GLAXF's market capitalization is $99,574,710,360.00, placing it in the large-cap tier.

Does GLAXF pay a dividend?

Yes. GLAXF has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

GSK plc (GLAXF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - General

$24.85

Market Cap

$99.57B

PE (TTM)

16.80

EPS (TTM)

N/A

Dividend Yield

3.75%

Beta

0.30

Day Range

$22.77 – $24.85

52-wk Range

$21.69 – $31.48

Avg Volume

N/A

Volume

4.00

GSK plc (GLAXF) is a publicly traded company in the Healthcare sector. Latest price: $24.85. Market cap $99.57B. Trailing PE 16.80. Dividend yield 3.75%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 11 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $23.30 2026-10-28 · $24.85 (+6.65%)

Earnings

Most Recent

Oct 28, 2026

EPS $0.72 vs est. $0.67

Beat by $0.06

Next Earnings

Feb 3, 2027

EPS estimate $0.39

Proprietary Signals

Signal snapshot temporarily unavailable.

About GSK plc

GSK plc, a global healthcare and pharmaceutical leader with roots tracing back to 1715, is headquartered in Brentford, United Kingdom. Operating extensively across the UK, United States, and other international markets, its activities span the entire lifecycle of healthcare products, encompassing research, development, manufacturing, and commercialization. Its broad portfolio includes pharmaceuticals, vaccines, over-the-counter medications, and a range of health-focused consumer products. The company operates through four primary divisions: Pharmaceuticals, Pharmaceutical Research & Development, Vaccines, and Consumer Healthcare. Within its pharmaceutical arm, GSK provides therapeutic solutions for a broad spectrum of conditions. These include ailments in respiratory health, HIV, immuno-inflammation, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital issues, metabolic diseases, bacterial infections, and dermatology. The consumer healthcare division delivers products across wellness, oral health, nutrition, and skin health categories. These are available in numerous formats, including nasal sprays, tablets, syrups, lozenges, gum and transder…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	16.80×
P/S (TTM)	2.17×
P/B	3.88×
P/FCF (TTM)	10.63×
EV / EBITDA	8.78×
EV / Sales	2.79×
Earnings Yield	5.98%
Free Cash Flow Yield	9.41%
Dividend Yield	3.75%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$93.45B
Revenue (TTM)	$33.54B
Net Income (TTM)	$4.35B
Free Cash Flow (TTM)	$6.80B
Net Debt	$20.77B
Working Capital	-$2.83B
Gross Margin	73.52%
Operating Margin	23.80%
Net Margin	12.97%
Return on Equity	24.64%
Return on Invested Capital	13.50%